Life Sciences
-

BlueHealth Innovation Fund
The BlueHealth Innovation Fund is an investment fund that invests in health tech startups emerging from imec.istart. It makes investments through an open-call procedure three times per year, when startups can pitch for a €50,000 investment. The fund is backed by university hospital UZA, as well as pharmaceutical group UCB, entrepreneurship consultancy Cronos Groep, and In4Care, a healthcare innovation association.
-

imec.istart Future Fund
The imec.istart Future Fund is an independent capital fund focused primarily on startups emerging from the imec.istart ecosystem. The fund invests from the late seed to series A stages, committing up to €2.5 million per company. It seeks out opportunities in Belgium, the Netherlands, and Italy.
-

Freiraum Ventures
Freiraum Ventures operates out of the Strascheg Center for Entrepreneurship (SCE) at the Munich University of Applied Science. It invests in early-stage spinouts, writing cheques from €50,000 to €200,000. The fund is backed by Prof Dr Falk Strascheg, who is also a founding partner of VC firm EXTOREL Private Equity Advisers.
-

GF BRYCK Ventures
GF BRYCK Ventures is an early-stage investment fund targeting spinouts from Ruhr University Bochum, TU Dortmund, and the University of Duisburg-Essen. It invests €300,000 per company, targeting 10 to 20 investments per year. The fund builds on a partnership between BRYCK, a German innovation and startup hub, and the University Alliance Ruhr, comprising the three aforementioned universities, which began in 2023 to foster more startups and spinouts. The fund is managed by Gründerfonds Ruhr, with the entire €10 million commitment coming from the RAG-Stiftung, a private foundation that finances the long-term obligations of Germany’s former coal mining operations in the…
-

KHAN Technology Transfer Fund
KHAN Technology Transfer Fund focuses on early-stage life sciences investments, particularly first-in-class therapies for indications with a high unmet medical need. Its pipeline is sourced primarily from research institutes such as those belonging to the Max Planck Society, with which it has a preferred partnership and a co-investment agreement worth €18 million. KHAN also has access to the drug discovery incubator Lead Discovery Center, established by the tech transfer office Max Planck Innovation.
-

CentraleSupélec Venture
CentraleSupélec Venture invests in startups from the ecosystem of French grande école CentraleSupélec.
-

Eureka! Fund I – Technology Transfer
The Eureka! Fund I focuses on on proof of concept, seed and early stage spinouts emerging from Italian universities and research centres.
-

KIT Gründerschmiede
KIT Gründerschmiede is the innovation and investment arm of the Karlsruhe Institute of Technology.
-

LIFTT
LIFTT was formed by LINKS Foundation, itself a joint venture of the Politecnico di Torino and Compagnia di San Paolo.
-

Tech Europe Foundation
Tech Europe Foundation was co-founded by Fondazione Politecnico di Milano and Bocconi University.
-

Sorbonne Venture
Sorbonne Venture is a planned €100 million investment fund launched by Sorbonne University.
-

Aleap Ventures
Aleap Ventures is an early-stage life sciences investemtn fund connected to the Aleap incubator in Oslo.
-

Delphinus Venture Capital
Delphinus offers capital from the preseed to the scale-up stage and operates out of the city of Aarhus.
-

Voima Ventures
Voima Ventures invests in deep tech startups throughout the Nordics and Baltics. It evolved out of VTT Ventures.
-

VIVES
VIVES initially focused on the ecosystem around UCLouvain, but with the launch of its third fund, VIVES Inter-University Fund, expanded to include partners in France, Luxembourg, and the Netherlands.
-

Biotope Ventures
Biotope Ventures invests €350,000 per startup linked to the VIB’s Biotope incubator, in the form of a convertible loan.
-

V-Bio Ventures
V-Bio Ventures is an independent VC firm focused on life sciences. It works closely with VIB, a Flemish research institute spread across six universities.
-

Qbic
Qbic is a sector-agnostic seed and early-stage fund backing spinouts and startups from its partners, which include universities, hospitals, and research organisations. It typically participates from a company’s first round.
-

Polytechnique Ventures
Polytechnique Ventures is the seed fund of the École Polytechnique. It invests from preseed to series A (though may also back a series B in exceptional circumstances). It is financed by alumni.
-

Obuda Uni Venture Capital
OUVC, affiliated with Óbuda University in Budapest, Hungary, makes investments in preseed and seed-stage startups in healthcare, industrial automation, and sustainability.
-

imec.xpand
imec.xpand is a venture capital fund that focuses on transformative semiconductor and nanotechnology innovations.
-

i&i Biotech Fund
i&i Biotech Fund was established in cooperation with the European Investment Fund and i&i Prague. It focuses on spinouts in the life sciences, particularly drug discovery, diagnostics, medical devices, and biotech.
-

Carma Fund
Carma Fund is an early-stage investment fund focused on life sciences and healthtech. It invests throughout Europe, and operates out of Frankfurt am Main and Munich.


